Lower percentages of T regulatory cells in children with type 1 diabetes - Preliminary report

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 15, Issue 1, 2009, Pages 34-38

  Łuczyński, Włodzimierz ^a   Stasiak Barmuta, Anna ^b   Urban, Remigiusz ^b   Urban, Mirosława ^a   Florys, Bozena ^a   Hryszko, Marek ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF BIALYSTOK   (Poland)

^c Department of Radiology Voivodeship Specialistic Hospital in Bia ystok   (Poland)

Author keywords

Children; Immunotherapy; T lymphocytes; T regulatory cells; Type 1 diabetes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION; BLOOD CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; PATHOLOGY;

ADOLESCENT; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 79959230933     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tritt M., Sqouroudis E., d'Hennezel E., Albanese A., Piccirillo C.A.: Functional waning of naturally occuring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes, 2008, 57, 113-123.
2. Wu A.J., Hua H., Munson S.H., McDevitt H.O.: Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA, 2002, 99, 12287-12292.
3. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M.: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 1995, 155, 1151-1164.
4. Stassen M., Fondel S., Bopp T. , Richter C., Müller C., Kubach J., Becker C., Knop J., Enk A.H., Schmitt S., Schmitt E., Jonuleit H.: Human CD25+regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur. J. Immunol., 2004, 34, 1303-1311.
5. Hori S., Nomura T., Sakaguchi S.: Control of regulatory T cell development by the transcription factor FoxP3. Science, 2003, 299, 1057-1061. (Pubitemid 36222930)
6. Antons A.K., Wang R., Oswald-Richter K., Tseng M., Arendt C.A., Kalams S.A., Unutmaz D.: Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J. Immunol., 2008, 180, 764-773.
7. Roncador G., Brown P.J., Maestre L., Hue S., Martínez- Torrecuadrada J.L., Ling K.L., Pratap S., Toms C., Fox B.C., Cerundolo V., Powrie F., Banham A.H.: Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol., 2005, 35, 1681-1691.
8. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., Clayberger C., Soper D.M., Ziegler S.F., Bluestone J.A.: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med., 2006, 203, 1701-1711.
9. Shevach E.M.: Special regulatory T cell review: how I became a T suppressor/regulatory cell maven. Immunol., 2008, 123, 3-5. (Pubitemid 350256013)
10. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., Tree T.I.: Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes, 2005, 54, 92-99. (Pubitemid 40105099)
11. Wang R., Han G., Wang J., Song L., Chen G., Xu R., Yu M., Qian J., Shen B., Li Y.: Foxp3-expressing CD4(+) T cells under the control of IFN-gamma promoter prevent diabetes in NOD mice. Mol. Ther., 2007, 15, 1551-1557.
12. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., Maclaren N.: Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest., 2002, 109, 131-140.
13. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., Cross R., Sehy D., Blumberg R.S., Vignali D.A.: The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 2007, 450, 566-569. (Pubitemid 350190247)
14. Stummvoll G.H., DiPaolo R.J., Huter E.N., Davidson T.S., Glass D., Ward J.M., Shevach E.M.: Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol., 2008, 181, 1908-1916.
15. Ochoa-Repáraz J., Rynda A., Ascón M.A., Yang X., Kochetkova I., Riccardi C., Callis G., Trunkle T., Pascual D.W.: IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J. Immunol., 2008, 181, 954-968.
16. Brusko T., Atkinson M.: Treg in type 1 diabetes. Cell. Biochem. Biophys., 2007, 48, 165-175.
17. Glisic-Milosavljevic S., Waukau J., Jailwala P., Jana S., Khoo H.J., Albertz H., Woodliff J., Koppen M., Alemzadeh R., Hagopian W., Ghosh S.: At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction. PLoS ONE, 2007, 2, e146.
18. Oling V., Marttila J., Knip M., Simell O., Ilonen J.: Circulating CD4+CD25high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies. Ann. N. Y. Acad. Sci., 2007, 1107, 363-372.
19. Brusko T., Wasserfall C., McGrail K., Schatz R., Viener H.L., Schatz D., Haller M., Rockell J., Gottlieb P., Clare-Salzer M., Atkinson M.: No alterations in the frequency of FoxP3+ regulatory T-cells in type 1 diabetes. Diabetes, 2007, 56, 604-612.
20. Glisic-Milosavljevic S., Wang T., Koppen M., Kramer J., Ehlenbach S., Waukau J., Jailwala P., Jana S., Alemzadeh R., Ghosh S.: Dynamic changes in CD4+CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes. Clin. Exp. Immunol., 2007, 150, 75-82.
21. Gregg R.K., Jain R., Schoenleber S.J., Divekar R., Bell J.J., Lee H.H., Yu P., Zaghouani H.: A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J. Immunol., 2004, 173, 7308-7316. (Pubitemid 39628168)
22. Luo X., Tarbell K.V., Yang H., Pothoven K., Bailey S.L., Ding R., Steinman R.M., Suthanthiran M.: Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective FoxP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA, 2007, 104, 2821-2826.
23. Jaeckel E., von Boehmer H., Manns M.P.: Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes, 2005, 54, 306-310.
24. Tarbell K.V., Petit L., Zuo X., Toy P., Luo X., Mqadmi A., Yang H., Suthanthiran M., Mojsov S., Steinman R.M.: Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med., 2007, 204, 191-201.